TY - JOUR
T1 - Addressing stem cell therapeutic approaches in pathobiology of diabetes and its complications
AU - Peng, Bou Yue
AU - Dubey, Navneet Kumar
AU - Mishra, Viraj Krishna
AU - Tsai, Feng Chou
AU - Dubey, Rajni
AU - Deng, Win Ping
AU - Wei, Hong Jian
N1 - Publisher Copyright:
Copyright © 2018 Bou-Yue Peng et al. This is an open access article distributed under the Creative Commons Attribution License
PY - 2018/1/1
Y1 - 2018/1/1
N2 - High morbidity and mortality of diabetes mellitus (DM) throughout the human population is a serious threat which needs to be addressed cautiously. Type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) are most prevalent forms. Disruption in insulin regulation and resistance leads to increased formation and accumulation of advanced end products (AGEs), which further enhance oxidative and nitrosative stress leading to microvascular (retinopathy, neuropathy, and nephropathy) and macrovascular complications. These complications affect the normal function of organ and tissues and may cause life-threatening disorders, if hyperglycemia persists and improperly controlled. Current and traditional treatment procedures are only focused on to regulate the insulin level and do not cure the diabetic complications. Pancreatic transplantation seemed a viable alternative; however, it is limited due to lack of donors. Cell-based therapy such as stem cells is considered as a promising therapeutic agent against DM and diabetic complications owing to their multilineage differentiation and regeneration potential. Previous studies have demonstrated the various impacts of both pluripotent and multipotent stem cells on DM and its micro- and macrovascular complications. Therefore, this review summarizes the potential of stem cells to treat DM and its related complications.
AB - High morbidity and mortality of diabetes mellitus (DM) throughout the human population is a serious threat which needs to be addressed cautiously. Type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) are most prevalent forms. Disruption in insulin regulation and resistance leads to increased formation and accumulation of advanced end products (AGEs), which further enhance oxidative and nitrosative stress leading to microvascular (retinopathy, neuropathy, and nephropathy) and macrovascular complications. These complications affect the normal function of organ and tissues and may cause life-threatening disorders, if hyperglycemia persists and improperly controlled. Current and traditional treatment procedures are only focused on to regulate the insulin level and do not cure the diabetic complications. Pancreatic transplantation seemed a viable alternative; however, it is limited due to lack of donors. Cell-based therapy such as stem cells is considered as a promising therapeutic agent against DM and diabetic complications owing to their multilineage differentiation and regeneration potential. Previous studies have demonstrated the various impacts of both pluripotent and multipotent stem cells on DM and its micro- and macrovascular complications. Therefore, this review summarizes the potential of stem cells to treat DM and its related complications.
UR - http://www.scopus.com/inward/record.url?scp=85052060175&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052060175&partnerID=8YFLogxK
U2 - 10.1155/2018/7806435
DO - 10.1155/2018/7806435
M3 - Article
AN - SCOPUS:85052060175
SN - 2314-6745
VL - 2018
JO - Journal of Diabetes Research
JF - Journal of Diabetes Research
M1 - 7806435
ER -